Literature DB >> 1577656

Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988).

G J Spodnick1, J Berg, W M Rand, S H Schelling, G Couto, H J Harvey, R A Henderson, G MacEwen, N Mauldin, D L McCaw.   

Abstract

Long-term follow-up information pertaining to 162 dogs with appendicular osteosarcoma treated by amputation alone was collected from 17 veterinary institutions. The majority (72.5%) of dogs died or were euthanatized because of problems documented to be related to metastases. The first clinically apparent sites of metastasis were the lungs (60.8% of total), the skeleton (5.2%), or both (4.6%). A Kaplan-Meier survivorship distribution was plotted on the basis of available survival time data in all 162 dogs. The mean and median survival times were estimated to be 19.8 and 19.2 weeks, respectively, and the 1- and 2-year survival rates were estimated to be 11.5 and 2.0% respectively. Statistically significant relationships were not found between survival time and reporting institution, gender, site of primary tumor, whether the primary tumor was proximally or distally located, whether the primary tumor was located in the forelimb or hind limb, whether presurgical biopsy was performed, and whether death was tumor related. A significant (P less than 0.01) quadratic relationship was found between age and survival time. Survival time was longest in dogs 7 to 10 years old and was shorter in older and younger dogs.

Entities:  

Mesh:

Year:  1992        PMID: 1577656

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  44 in total

Review 1.  Recent and current clinical trials in canine appendicular osteosarcoma.

Authors:  Andrew C Poon; Arata Matsuyama; Anthony J Mutsaers
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

2.  Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.

Authors:  M McMahon; T Mathie; N Stingle; E Romansik; D Vail; C London
Journal:  J Vet Intern Med       Date:  2011-04-12       Impact factor: 3.333

3.  Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.

Authors:  Tobie D Wolfe; Smitha Pankajavally Somanathan Pillai; Blake Eason Hildreth; Lisa G Lanigan; Chelsea K Martin; Jillian L Werbeck; Thomas J Rosol
Journal:  Clin Exp Metastasis       Date:  2011-03-04       Impact factor: 5.150

Review 4.  Species differences in tumour responses to cancer chemotherapy.

Authors:  Jessica Lawrence; David Cameron; David Argyle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

5.  The impact of carboplatin and toceranib phosphate on serum vascular endothelial growth factor (VEGF) and metalloproteinase-9 (MMP-9) levels and survival in canine osteosarcoma.

Authors:  Tracy L Gieger; Julie Nettifee-Osborne; Briana Hallman; Chad Johannes; Dawn Clarke; Michael W Nolan; Laurel E Williams
Journal:  Can J Vet Res       Date:  2017-07       Impact factor: 1.310

6.  Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival.

Authors:  Agneta Egenvall; Ane Nødtvedt; Henrik von Euler
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

7.  The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro.

Authors:  James P Farese; Jenna Ashton; Rowan Milner; Linda-Lee Ambrose; James Van Gilder
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Mar-Apr       Impact factor: 2.416

Review 8.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

9.  Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell lines.

Authors:  J A Lawrence; M K Huelsmeyer; D H Thamm; D B Tumas; G Birkus; I Kurzman; D M Vail
Journal:  Vet Comp Oncol       Date:  2013-05-15       Impact factor: 2.613

10.  Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.

Authors:  Gayathri T Selvarajah; Jolle Kirpensteijn; Monique E van Wolferen; Nagesha A S Rao; Hille Fieten; Jan A Mol
Journal:  Mol Cancer       Date:  2009-09-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.